9 hours ago • PR Newswire
Innovent Announces Completion of First Participant Dosed in the Seventh Phase 3 Clinical Trial (GLORY-OSA) of Mazdutide in China
9 hours ago • PR Newswire
Innovent Announces Completion of First Participant Dosed in the Seventh Phase 3 Clinical Trial (GLORY-OSA) of Mazdutide in China2025-06-13 • PR Newswire
Innovent to Present Multiple R&D Results of General Biomedicine Pipeline at the ADA's 85th Scientific Sessions2025-06-05 • PR Newswire
Innovent's IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Receives Second NMPA Breakthrough Therapy Designation for Immuno-resistant Squamous Non-Small Cell Lung Cancer2025-06-05 • PR Newswire
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Renal Cell Carcinoma2025-06-04 • PR Newswire
2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from the Phase 1 PoC Clinical Study in Advanced Non-small Cell Lung Cancer2025-06-03 • PR Newswire
2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors2025-06-03 • PR Newswire
ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI343 (Novel Anti-CLDN18.2 ADC) From the Phase 1 Clinical Study in Patients with Advanced Pancreatic Cancer2025-06-02 • PR Newswire
2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Date of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from Phase 1 Clinical Studies in Advanced Colorectal Cancer2025-06-01 • PR Newswire
ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein) from Phase 1 and 2 Clinical Studies on Immunotherapy-treated Advanced Malignant Melanoma2025-05-29 • PR Newswire
Innovent Announces a Phase 3 Study of Picankibart (Anti-IL-23p19 Antibody) Completes First Participant Dosing, Exploring Biologics Switching Treatment for Psoriasis Patients with Prior Inadequate Response to Anti-IL-17 Antibodies2025-05-26 • PR Newswire
Phase 3 Clinical Study of Mazdutide in Chinese Adults with Overweight or Obesity (GLORY-1) Published in The New England Journal of Medicine (NEJM)2025-05-19 • PR Newswire
Innovent Released 2024 ESG Report, Underscoring Commitment to Sustainable Development and Global Innovation2025-05-16 • PR Newswire
Second Head-to-head Phase 3 Study of Mazdutide versus Semaglutide Completes First Participant Dosing in Adults in China with Overweight or Obesity Accompanied Fatty Liver Disease (GLORY-3)3 minutes ago • prnewswire.co.uk
LNG Station Market worth $1.56 billion by 2030 | MarketsandMarkets™29 minutes ago • theconstructionindex.co.uk
Esh wins £160m sewer maintenance deal31 minutes ago • ontarioconstructionnews.com
Thunder Bay breaks ground on region’s first cardiovascular surgery program47 minutes ago • solarquarter.com
Sungrow Hydrogen & Wison Engineering Launch Revolutionary ‘Factory-As-A-Product’ Turnkey Green Hydrogen Solution At SNEC To Transform Industrial Production1 hour ago • prnewswire.co.uk
Astronergy sets the pace at SNEC 2025 with cutting-edge solar products and global partnerships1 hour ago • prnewswire.co.uk
Discover the Superhero Within: New Book Stories with Purpose by Laura G. Patac Helps Readers Turn Life's Challenges into Purpose1 hour ago • prnewswire.co.uk
Finastra Lands Top Payments Software Ranking with IBSi Sales League Table3 hours ago • nagalandtribune.in
Tripura has begun experimental soilless hydroponic farming: Minister3 hours ago • prnewswire.co.uk
Tetragon Financial Group Limited Announces Sale of Minority Equitix Stake to Hunter Point Capital5 hours ago • prnewswire.co.uk
Education Cannot Wait for the Children of Africa17 hours ago • theglobeandmail.com
Viking Therapeutics Stock (VKTX): This Underrated Russell 2000 Gem Could Skyrocket 200%17 hours ago • foxbusiness.com
Bethenny Frankel sells her Connecticut mansion for nearly $8M after major renovation17 minutes ago • EIN Presswire
Electronic Team Announces the Major Release of Donglify 2.0 with QUIC support and Improved Performance17 minutes ago • EIN Presswire
Groundbreaking New Book by Attorney Rebecca Sposita Transforms Complaints into Opportunities1 hour ago • EIN Presswire
Edge Point Group Releases Executive Guide to Digital Exposure: Revealing How Public Clues Quietly Create Risk2025-06-14 • eutoday.net
EU Set to Demand Full Disclosure of Russian Gas Contracts as Part of 2027 Phase-Out Plan23 hours ago • agronews.ua
EU introduces tariffs on all agricultural imports from Russia23 hours ago • nikvesti.com
Chemical plant producing components for explosives attacked in Russia1 hour ago • PR Newswire
Ravin Group Wins 'Outstanding Component Supplier for Railway Infrastructure' at ET Infra Rail Show Awards 20253 hours ago • nagalandtribune.in
Tripura has begun experimental soilless hydroponic farming: Minister4 hours ago • businesswireindia.com
Mirai School of Technology Is Changing Engineering in India - Here’s How Students Are Learning AI from Day One29 minutes ago • theconstructionindex.co.uk
Esh wins £160m sewer maintenance deal32 minutes ago • EIN Presswire
Global Icing Sugar Market Set to Reach USD 4.71 Billion by 2035 Amid Rising Artisanal Baking Trends47 minutes ago • EIN Presswire
Water Desalination Equipment Market to Surpass USD 26.1 Billion by 2035 Amid 8.4% CAGR GrowthStay ahead with real-time headlines from top sources, categorized by sector and country.